107.521 articles found

Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective.

Brocks DR.

J Pharm Pharm Sci · 1999-05-01

PMID: 10952768

[Clinical and demographic aspects of Parkinson's disease].

Larumbe R, Gaminde I, Viñes JJ.

An Sist Sanit Navar · 1999-05-01

DOI: 10.23938/assn.0503PMID: 12886354

Ropinirole in the treatment of Parkinson's disease.

Zesiewicz TA, Hauser RA.

Expert Opin Investig Drugs · 1999-05-01

DOI: 10.1517/13543784.8.5.697PMID: 15992124

RILUZOLE AND LEVODOPA COMBINATIONS FOR TREATING PARKINSON'S DISEASE

BLANCHARD-BREGEON Véronique, IMPERATO Assunta, MOUSSAOUI Saliha, OBINU Marie-Carmen, REIBAUD Michel.

· 1999-04-22

ASSOCIATIONS DE RILUZOLE ET DE LEVODOPA POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON

BLANCHARD-BREGEON Véronique, IMPERATO Assunta, MOUSSAOUI Saliha, OBINU Marie-Carmen, REIBAUD Michel.

· 1999-04-22

ASSOCIATION OF RILUZOLE AND LEVODOPA FOR THE TREATMENT OF PARKINSON DISEASE

IMPERATO ASSUNTA, BLANCHARD-BREGEON VERONIQUE, MOUSSAOUI SALIHA, OBINU MARIE-CARMEN, REIBAUD MICHEL.

· 1999-04-22

Riluzole and levodopa combinations for treating parkinson's disease

Check source for author details

· 1999-04-22

COMBINATION OF RILUSOL AND L-DOFA FOR TREATING PARKINSON'S DISEASE

BLANSHAR-BREZHEON VERONIK, IMPERATO ASSUNTA, MUSSAUI SALIA, OBINJU MARI-KARMEN, REJBO MISHEL.

· 1999-04-22

COMBINATION OF LEVODOPA AND RILUZOLE FOR TREATING COMBINATION OF LEVODOPA AND RILUZOLE FOR TREATING PARKINSON DISEASE PARKINSON DISEASE

Check source for author details

· 1999-04-22

Methods and apparatus for treatment of Parkinson's disease

KUSHNIR MOSHE, HELDMAN ELIAHU.

· 1999-04-07

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.

Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M.

J Biol Chem · 1999-04-01

DOI: 10.1074/jbc.274.14.9843PMID: 10092675

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Lee WY, Chang JW, Nemeth NL, Kang UJ.

J Neurosci · 1999-04-01

DOI: 10.1523/jneurosci.19-08-03266.1999PMID: 10191339